---
title: "Double the GEM, amplify the power of A-shares."
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/39530351.md"
description: "$Bosera China GEM Index Daily Leveraged (2X) Product (07234.HK)$ChiNext Index (399006.SZ) ChiNext Index year-to-date gain +3.55%Performance table of the top 20 constituent stocks of the Shenzhen Stock Exchange ChiNext Board: Investment involves risks. Past investment performance is not necessarily indicative of future performance. Investors should not base their investment decisions solely on the information contained herein. The above information is for reference only and does not constitute and should not be regarded as an offer to subscribe or sell to anyone. Investors should read the relevant fund's prospectus and product key facts statement in detail before making any investment decision..."
datetime: "2026-03-26T01:36:11.000Z"
locales:
  - [en](https://longbridge.com/en/topics/39530351.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/39530351.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/39530351.md)
author: "[博时国际](https://longbridge.com/en/profiles/16136055.md)"
---

# Double the GEM, amplify the power of A-shares.

[$Bosera China GEM Index Daily Leveraged (2X) Product (07234.HK)](https://longbridge.com/quote/07234.HK)[$GEM Index (399006.SZ)](https://longbridge.com/quote/399006.SZ)The GEM Index has gained +3.55% year-to-date.

Performance overview of the top 20 heavyweight stocks on the Shenzhen GEM:

Investment involves risks. Past investment performance may not be indicative of future results. Investors should not base their investment decisions solely on the information contained herein. The above information is for reference only and does not constitute and should not be considered as an offer to subscribe for or sell to any person. Before making any investment decision, investors should read in detail the relevant fund's constitutive documents and product key facts statement, including the product features and risk factors contained therein. Investors should assess whether the product is suitable for them based on factors such as their own investment experience, investment objectives, financial situation, and risk tolerance. Seek independent professional advice if necessary. The above information has not been reviewed by the Securities and Futures Commission of Hong Kong.

Issued by: Bosera International. No part of the information or any portion thereof contained in this document may be photocopied, distributed, or reproduced without the consent of Bosera International.[$Contemporary Amperex Technology Co. Limited (300750.SZ)](https://longbridge.com/quote/300750.SZ)[$East Money Information Co., Ltd. (300059.SZ)](https://longbridge.com/quote/300059.SZ)[$Inovance Technology Co., Ltd. (300124.SZ)](https://longbridge.com/quote/300124.SZ)[$Zhongji Innolight Co., Ltd. (300308.SZ)](https://longbridge.com/quote/300308.SZ)[$Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)](https://longbridge.com/quote/300760.SZ)[$Eoptolink Technology Inc., Ltd. (300502.SZ)](https://longbridge.com/quote/300502.SZ)[$Sungrow Power Supply Co., Ltd. (300274.SZ)](https://longbridge.com/quote/300274.SZ)[$Wens Foodstuff Group Co., Ltd. (300498.SZ)](https://longbridge.com/quote/300498.SZ)

### Related Stocks

- [300308.CN](https://longbridge.com/en/quote/300308.CN.md)
- [300274.CN](https://longbridge.com/en/quote/300274.CN.md)
- [399006.CN](https://longbridge.com/en/quote/399006.CN.md)
- [07234.HK](https://longbridge.com/en/quote/07234.HK.md)
- [300498.CN](https://longbridge.com/en/quote/300498.CN.md)
- [300059.CN](https://longbridge.com/en/quote/300059.CN.md)